...
首页> 外文期刊>Journal of Clinical Research Best Practices >Sites Will Be Operating in a World Focused on Customization After the Pandemic
【24h】

Sites Will Be Operating in a World Focused on Customization After the Pandemic

机译:网站将在大流行后重点关注定制的世界

获取原文
           

摘要

A clear focus on hybrid solutions and customization to a site’s needs will be the hallmarks of clinical trials post-pandemic, along with a strengthened ability to shorten trial timelines. Sites’ pandemic experience has not been a particularly rosy one, says Ken Getz, director of the Tufts Center for the Study of Drug Development (CSDD). “We’ve put a tremendous burden on sites to support the adjustments needed for the pandemic.” According to CSDD data, only 45 percent of trials continued business as usual during the pandemic, while 30 percent switched to remote and virtual models. An additional 25 percent were forced to delay trial activity altogether.
机译:明确关注混合解决方案和定制对网站需求的定制将是大流行后临床试验的标志,以及加强缩短试用时间表的能力。 塔夫茨药物开发研究中心(CSDD)的塔夫茨中心主任Ken Getz表示,网站的大流行经验并非特别玫瑰色。 “我们对网站带来了巨大的负担,以支持大流行所需的调整。” 根据CSDD数据,在大流行期间只有45%的试验持续持续业务,而30%的百分点转换为远程和虚拟模型。 另外25%被迫完全延迟试验活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号